HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen receptor beta-mediated nuclear interaction between IRS-1 and Rad51 inhibits homologous recombination directed DNA repair in medulloblastoma.

Abstract
In medulloblastomas, which are highly malignant cerebellar tumors of the childhood genotoxic treatments such as cisplatin or gamma-irradiation are frequently associated with DNA damage, which often associates with unfaithful DNA repair, selection of new adaptations and possibly tumor recurrences. Therefore, better understanding of molecular mechanisms which control DNA repair fidelity upon DNA damage is a critical task. Here we demonstrate for the first time that estrogen receptor beta (ERbeta) can contribute to the development of genomic instability in medulloblastomas. Specifically, ERbeta was found highly expressed and active in mouse and human medulloblastoma cell lines. Nuclear ERbeta was also present in human medulloblastoma clinical samples. Expression of ERbeta coincided with nuclear translocation of insulin receptor substrate 1 (IRS-1), which was previously reported to interfere with the faithful component of DNA repair when translocated to the nucleus. We demonstrated that ERbeta and IRS-1 bind each other, and the interaction involves C-terminal domain of IRS-1 (aa 931-1233). Following cisplatin-induced DNA damage, nuclear IRS-1 localized at the sites of damaged DNA, and interacted with Rad51--an enzymatic component of homologous recombination directed DNA repair (HRR). In medulloblastoma cells, engineered to express HRR-DNA reporter plasmid, ER antagonist, ICI 182,780, or IRS mutant (931-1233) significantly increased DNA repair fidelity. These data strongly suggest that both molecular and pharmacological interventions are capable of preventing ERbeta-mediated IRS-1 nuclear translocation, which in turn improves DNA repair fidelity and possibly counteracts accumulation of malignant mutations in actively growing medulloblastomas.
AuthorsKatarzyna Urbanska, Paola Pannizzo, Adam Lassak, Elisa Gualco, Eva Surmacz, Sidney Croul, Luis Del Valle, Kamel Khalili, Krzysztof Reiss
JournalJournal of cellular physiology (J Cell Physiol) Vol. 219 Issue 2 Pg. 392-401 (May 2009) ISSN: 1097-4652 [Electronic] United States
PMID19117011 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Estrogen Receptor beta
  • Insulin Receptor Substrate Proteins
  • Rad51 Recombinase
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Nucleus (metabolism)
  • DNA Repair
  • Estrogen Receptor beta (genetics, metabolism)
  • Humans
  • Insulin Receptor Substrate Proteins (genetics, metabolism)
  • Medulloblastoma (genetics, metabolism)
  • Mice
  • Rad51 Recombinase (genetics, metabolism)
  • Recombination, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: